Creo Medical flags 60pc rise in first-quarter revenue
29th Jun 2026 14:16
(Sharecast News) - Creo Medical said on Monday that first-quarter revenue rose about 60% year on year, at the upper end of management expectations, driven by customer adoption, higher procedure volumes and conversion of its commercial pipeline.
Read moreCreo Medical's SpydrBlade Flex device receives US FDA clearance
11th Jun 2025 07:44
(Sharecast News) - Medical devices company Creo Medical Group said on Wednesday that its SpydrBlade Flex device has received US Food & Drug Administration clearance.
Read moreCreo Medical eyes transition to full commercialisation in FY25
17th Feb 2025 08:00
(Sharecast News) - Medical device company Creo Medical said on Monday that it would transition from development to full commercialisation in FY25.
Read moreDirector dealings: Creo Medical chairman raises stake
16th Dec 2024 15:27
(Sharecast News) - Creo Medical revealed on Monday that chairman Kevin Crofton had acquired 1.17m ordinary shares in the London-listed medical device company.
Read moreCreo Medical extends closing date for retail offer
4th Oct 2024 16:10
(Sharecast News) - Creo Medical Group announced an extension to the closing date for its retail offer on Friday, allowing existing retail shareholders more time to participate.
Read moreCreo Medical reports year of solid progress
26th Jun 2024 13:43
(Sharecast News) - Surgical endoscopy medical device specialist Creo Medical Group reported solid progress over the last 12 months in an update on Wednesday, as it leveraged funds from the March 2023 equity raise to advance its strategic goals.
Read moreCreo device used in 'groundbreaking' lung cancer procedure
1st Mar 2024 14:06
(Sharecast News) - Creo Medical Group announced a significant milestone in the field of minimally-invasive surgical endoscopy for cancer patients on Friday, with its 'MicroBlate Flex' device.
Read moreCreo Medical FY revenues up double digits
7th Feb 2024 11:49
(Sharecast News) - Medical device company Creo Medical said on Wednesday that 2023 was "a pivotal year" for the firm, with new products supporting "strong growth" and leading to a double-digit jump in group revenues.
Read moreCreo launches 'Speedboat Ultraslim' with first UK procedure
13th Dec 2023 14:28
(Sharecast News) - Creo Medical Group announced a significant milestone for its Speedboat UltraSlim medical device in the field of surgical endoscopy on Wednesday.
Read moreCreo Medical gets US FDA clearance for Speedboat UltraSlim
1st Nov 2023 14:28
(Sharecast News) - Medical device company Creo Medical Group announced on Wednesday that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Speedboat UltraSlim device.
Read moreCreo Medical accelerating EU launch of Speedboat UltraSlim
25th Oct 2023 13:44
(Sharecast News) - Creo Medical Group announced the acceleration of its EU launch of the 'Speedboat UltraSlim' device by around 18 months on Wednesday.
Read moreCreo Medical's 'Speedboat Inject' used for first time in Europe
26th Jun 2023 10:35
(Sharecast News) - Surgical endoscopy specialist Creo Medical announced on Monday that Dr Adolfo Parra-Blanco at Nottingham University Hospital NHS Trust had become the first clinician to perform an upper gastrointestinal (GI) tract 'Speedboat Inject' case in Europe, since clearance was gained last week.
Read moreCreo's Speedboat Inject to be evaluated by NICE
1st Jun 2023 15:14
(Sharecast News) - Surgical endoscopy specialist Creo Medical Group announced on Thursday that its 'Speedboat Inject' product had been chosen by the National Institute for Health and Care Excellence (NICE) for further evaluation and guidance in the endoscopic submucosal dissection (ESD) of lower gastrointestinal (GI) lesions.
Read moreCreo Medical achieves second Albyn earn-out target
14th Apr 2023 12:10
(Sharecast News) - Creo Medical Group announced on Friday that it has successfully achieved the earn-out target for the 12 months ended July last year, over the acquisition of Albyn Medical.
Read moreCreo raising at least £25m to progress various programmes
16th Feb 2023 18:19
(Sharecast News) - Medical device developer Creo Medical Group announced a fundraising of at least £25m net of expenses on Thursday, to progress its electrosurgical device programmes.
Read more